These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7162563)

  • 1. Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin.
    Rojas-Ramirez JA; Crawley JN; Mendelson WB
    Neuropeptides; 1982 Dec; 3(2):129-38. PubMed ID: 7162563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin (CCK-8) elicits prandial sleep in rats.
    Mansbach RS; Lorenz DN
    Physiol Behav; 1983 Feb; 30(2):179-83. PubMed ID: 6302718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal injection of cholecystokinin elicits sleep in rabbits.
    Kapás L; Obál F; Opp MR; Johannsen L; Krueger JM
    Physiol Behav; 1991 Dec; 50(6):1241-4. PubMed ID: 1798781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature.
    Kapás L; Obál F; Alföldi P; Rubicsek G; Penke B; Obál F
    Brain Res; 1988 Jan; 438(1-2):155-64. PubMed ID: 3345423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-B (CCK-B) receptor antagonists improve "aged" sleep: a new class of sleep modulators?
    Crespi F
    Methods Find Exp Clin Pharmacol; 1999; 21(1):31-8. PubMed ID: 10222445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men.
    Ahnaou A; de Boer P; Lavreysen H; Huysmans H; Sinha V; Raeymaekers L; Van De Casteele T; Cid JM; Van Nueten L; Macdonald GJ; Kemp JA; Drinkenburg WH
    Neuropharmacology; 2016 Apr; 103():290-305. PubMed ID: 26686390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cholecystokinin induce physiological satiety and sleep?
    de Saint Hilaire-Kafi Z; Depoortere H; Nicolaïdis S
    Brain Res; 1989 May; 488(1-2):304-10. PubMed ID: 2743125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic intracerebroventricular infusion of cholecystokinin on respiration and sleep.
    DeMesquita S; Haney WH
    Brain Res; 1986 Jul; 378(1):127-32. PubMed ID: 3742195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and electroencephalographic effects of the adenosine1 agonist, L-PIA.
    Martin JV; Berman KF; Skolnick P; Mendelson WB
    Pharmacol Biochem Behav; 1989 Nov; 34(3):507-10. PubMed ID: 2623008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin promotes sleep and reduces food intake in diabetic rats.
    Kapás L; Obál F; Farkas I; Payne LC; Sáry G; Rubicsek G; Krueger JM
    Physiol Behav; 1991 Aug; 50(2):417-20. PubMed ID: 1745688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a highly selective central CCK-B receptor agonist: BC-264 on rat sleep.
    de Saint Hilaire Z; Roques BP; Nicolaïdis S
    Pharmacol Biochem Behav; 1991 Mar; 38(3):545-8. PubMed ID: 2068190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat.
    Trampus M; Ongini E
    Neuropharmacology; 1990 Oct; 29(10):889-93. PubMed ID: 2147740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal cholecystokinin-8 induces atypical somnolence and EEG changes.
    Depoortere H; De Saint-Hilaire Z; Nicolaïdis S
    Physiol Behav; 1990 Dec; 48(6):873-7. PubMed ID: 2087520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin accelerates the rate of habituation to a novel environment.
    Crawley JN
    Pharmacol Biochem Behav; 1984 Jan; 20(1):23-7. PubMed ID: 6320229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of central and peripheral cholecystokinin in mediating appetitive behaviors.
    Crawley JN; Rojas-Ramirez JA; Mendelson WB
    Peptides; 1982; 3(3):535-8. PubMed ID: 6289285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ICV administration of neurotensin and analogs on EEG in rats.
    Castel MN; Stutzmann JM; Lucas M; Lafforgue J; Blanchard JC
    Peptides; 1989; 10(1):95-101. PubMed ID: 2748429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
    Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
    Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an alkaloid-rich extract from Mitragyna speciosa leaves and fluoxetine on sleep profiles, EEG spectral frequency and ethanol withdrawal symptoms in rats.
    Cheaha D; Keawpradub N; Sawangjaroen K; Phukpattaranont P; Kumarnsit E
    Phytomedicine; 2015 Oct; 22(11):1000-8. PubMed ID: 26407942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G; Itoh S
    Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.